Opendata, web and dolomites

SCREENED SIGNED

A multistage model of thyroid gland function for screening endocrine-disrupting chemicals in a biologically sex-specific manner

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 SCREENED project word cloud

Explore the words cloud of the SCREENED project. It provides you a very rough idea of what is the project "SCREENED" about.

gain    biological    3d    modular    structure    supporting    equipped    mechanistic    ultimately    endocrine    decellularized    hosted    groups    dimensional    bioprinted    models    constructs    engage    stakeholder    function    fit    morphogenetic    thyroid    anatomy    screened    vivo    ed    reproduce    assessment    purpose    geometrical    performance    superparamagnetic    assays    adverse    effect    classes    anatomical    vitro    architecture    precise    specificity    human    mode    stem    vascular    proteogenomics    sensitivity    industry    culture    screen    native    sex    spatiotemporal    organoids    predict    events    disruptors    organoid    cells    rodent    scaffold    magnetic    regulatory    homing    eds    individually    doses    safety    outcome    complexity    innovative    mimic    microbioreactor    particles    replication    composition    2d    cell    sensing    gland    bodies    construct    chain    spatial    underlying    exposure    biomimetic    animal    biocompatible    repopulated    action   

Project "SCREENED" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITEIT MAASTRICHT 

Organization address
address: Minderbroedersberg 4-6
city: MAASTRICHT
postcode: 6200 MD
website: http://www.maastrichtuniversity.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 5˙655˙088 €
 EC max contribution 5˙655˙088 € (100%)
 Programme 1. H2020-EU.3.1.1. (Understanding health, wellbeing and disease)
 Code Call H2020-SC1-2018-Single-Stage-RTD
 Funding Scheme RIA
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2023-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITEIT MAASTRICHT NL (MAASTRICHT) coordinator 1˙795˙750.00
2    UNIVERSITA DEGLI STUDI DI PARMA IT (PARMA) participant 1˙000˙000.00
3    ARTTIC FR (PARIS) participant 564˙781.00
4    UNIVERSITE LIBRE DE BRUXELLES BE (BRUXELLES) participant 499˙200.00
5    PRESENS PRECISION SENSING GMBH DE (Regensburg) participant 493˙750.00
6    CONSIGLIO NAZIONALE DELLE RICERCHE IT (ROMA) participant 400˙000.00
7    CYPROTEX DISCOVERY LIMITED UK (ABINGDON OXFORDSHIRE) participant 351˙440.00
8    UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN IE (DUBLIN) participant 300˙167.00
9    ATTUROS LIMITED IE (LIMERICK CLARE) participant 250˙000.00

Map

 Project objective

SCREENED will develop 3 different three-dimensional (3D) in vitro assays based on rodent and human thyroid cell constructs. At different level of anatomical complexity, these assays will increasingly mimic the structure and function of the native thyroid gland, ultimately achieving the replication of its vascular anatomy and morphogenetic characteristics: 1) a 3D organoid based on stem-cell derived thyroid cells, 2) a decellularized scaffold able to reproduce the biological composition of a native thyroid, repopulated by the 3D organoids, and 3) a bioprinted construct with the 3D organoids able to mimic the spatial and geometrical architecture of a native thyroid. These 3D assays will be hosted in a modular microbioreactor equipped with innovative sensing technology and enabling precise control of cell culture conditions. New superparamagnetic biocompatible and biomimetic particles will be used to produce “magnetic cells” to support precise spatiotemporal homing of the cells in the 3D decellularized and bioprinted constructs. The 3D assays will be used to screen the effect of endocrine disruptors (EDs) on the thyroid function in a unique biological sex-specific approach. Their performance will be assessed individually, in comparison with each other, and against in vivo studies. The 3D assays are expected to predict with more sensitivity and specificity the thyroid responses to different classes of EDs at low doses, compared to classical 2D in vitro assays or animal models. Supporting the “Adverse Outcome Pathway” concept, proteogenomics analysis and biological modelling of the underlying mode of action will be used to gain a mechanistic understanding of the chain of events from exposure to adverse effects on thyroid development and function. For future uptake, SCREENED will engage discussion with relevant stakeholder groups, including regulatory bodies and industry, to ensure that the assays are fit for purpose for ED safety assessment

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SCREENED" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SCREENED" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.1.)

DECISION (2020)

DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES

Read More  

ENDpoiNTs (2019)

Novel Testing Strategies for Endocrine Disruptors in the Context of Developmental NeuroToxicity

Read More  

BIND (2020)

Brain Involvement iN Dystrophinopathies

Read More